Nuveen, LLC Werewolf Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 73,370 shares of HOWL stock, worth $68,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,370Holding current value
$68,967% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HOWL
# of Institutions
72Shares Held
27.8MCall Options Held
12KPut Options Held
14K-
Ra Capital Management, L.P. Boston, MA6.14MShares$5.78 Million0.15% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$4.03 Million5.1% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.91MShares$2.73 Million0.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$2.24 Million0.53% of portfolio
-
Bank Of America Corp Charlotte, NC2.08MShares$1.95 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $27.8M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...